Covidien Ltd. to Report First-Quarter Results on February 7, 2008.HAMILTON Hamilton, city, Bermuda Hamilton, city (1990 est. pop. 3,100), capital of Bermuda, on Bermuda Island. It is a port at the head of Great Sound, a huge lagoon and deepwater harbor protected by coral reefs. , Bermuda Bermuda (bûrmy  `də), British dependency (2005 est. pop. 65,400), 21 sq mi (53 sq km), comprising some 150 coral rocks, islets, and islands (of which some 20 are inhabited), in the -- Covidien Ltd. (NYSE NYSESee: New York Stock Exchange : COV COV Composés Organiques Volatiles (French) COV Compuestos Orgánicos Volátiles (Spanish: Volatile Organic Compounds) COV Coefficient of Variation COV City of Villians (game) , BSX BSX Bermuda Stock Exchange BSX Bandai Satellaview-X BSX Bicycle Super-X (Cross) : COV) will report first-quarter results before trading begins on February February: see month. 7, 2008. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways: * At Covidien's website: http://investor.covidien.com * By telephone: For both "listen-only" participants and those participants who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 866-713-8310. For participants outside the U.S., the dial-in number is 617-597-5308. The access code for all callers is 96941212. * Through an audio replay: A replay of the conference call will be available beginning at 10:30 a.m. on February 7, 2008, and ending at 11:59 p.m. on February 14, 2008. The dial-in number for U.S. participants is 888-286-8010. For participants outside the U.S., the replay dial-in number is 617-801-6888. The replay access code for all callers is 98144838. ABOUT COVIDIEN Covidien is a leading global healthcare products company that creates innovative medical solutions for better patient outcomes and delivers value through clinical leadership and excellence. Covidien manufactures, distributes and services a diverse range of industry-leading product lines in five segments: Medical Devices, Pharmaceutical Products, Imaging Solutions, Medical Supplies and Retail Products. With 2007 revenue of $10 billion, Covidien has more than 43,000 employees worldwide in 57 countries, and its products are sold in over 130 countries. Please visit www.covidien.com to learn more about our business. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion